Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken option

Saved in:

Bibliographic Details
Published in:	Transl Lung Cancer Res
Main Authors:	Ricciuti, Biagio, Lamberti, Giuseppe, Roila, Fausto, Metro, Giulio
Format:	Artigo
Language:	Inglês
Published:	AME Publishing Company 2019
Subjects:	Editorial Commentary
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC6987338/ https://ncbi.nlm.nih.gov/pubmed/32038919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.04.15
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items